
01/09/2023
‼️
***FDA Advisory No.2023-1836***
All healthcare professionals and the general public are hereby advised by the Food and Drug Administration (FDA) regarding the voluntary recall by the marketing authorization holder (MAH) on the affected batch of the subject product from the market. The details of the product are as follows:
1. Specific Batch of Cefuroxime Axetil 125 mg/5 mL Suspension [Zinnat] 70 mL
Read more:-> https://bit.ly/3OrlJzb